Neuromuscular blocking properties of dioxonium

Area of Science:

• Anesthesiology
• Pharmacology
• Neuromuscular Pharmacology

Background:

• Neuromuscular blocking agents are crucial in anesthesia for facilitating endotracheal intubation and surgical procedures.
• Understanding the characteristics of novel agents like dioxonium (Dx) is essential for optimizing their clinical application.
• Comparing Dx with established agents such as d-tubocurarine (dTc) and suxamethonium (Sx) provides valuable insights into its efficacy and safety profile.

Purpose of the Study:

• To characterize the neuromuscular blocking properties of dioxonium (Dx) in surgical patients.
• To compare the onset, maintenance, and recovery phases of Dx-induced blockade with d-tubocurarine and suxamethonium.
• To investigate the relationship between twitch force and electromyogram (EMG) during Dx blockade and reversal.

Main Methods:

• Evaluation of neuromuscular block in surgical patients using ulnar nerve stimulation.
• Measurement of thumb adduction force and electromyogram (EMG) response to various nerve stimuli.
• Sequential administration of dioxonium (Dx) and comparison with d-tubocurarine (dTc) and suxamethonium (Sx).
• Assessment of block characteristics including fade, train-of-four (TOF) response, and dose-potency.

Main Results:

• Dioxonium (Dx) initially produced a depolarizing block with minimal fade, approximately 15 times more potent than d-tubocurarine (dTc).
• During maintenance, Dx exhibited nondepolarizing characteristics with significant fade, accompanied by tachyphylaxis and a greater suppression of EMG amplitude than twitch force.
• Recovery from Dx block was faster than from dTc, and neostigmine effectively reversed the block, although some EMG/force discrepancy persisted.

Conclusions:

• Dioxonium (Dx) displays a unique biphasic neuromuscular blocking profile, transitioning from depolarizing to nondepolarizing characteristics.
• Its potency and dynamic blockade properties necessitate careful dose titration and monitoring during surgical procedures.
• Further research is warranted to fully elucidate the clinical implications of Dx's distinct pharmacological behavior and potential for residual block.